SavedAdd your journal

Journals / Sağlık Bilimleri Üniversitesi Hemşirelik Dergisi / 2026 / Cilt: 3 Sayı: 2

Management of Lifestyle Change in Peripheral Arterial Disease: What Can Be Done?

Periferik Arter Hastalığında Yaşam Tarzı Değişikliğinin Yönetimi: Neler Yapılabilir?

Semiha Alkan Kayhan(SBÜ TRABZON AHİ EVRAN GÖĞÜS KALP VE DAMAR CERRAHİSİ EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0001-9826-1708
Ebru Güner(SBÜ TRABZON AHİ EVRAN GÖĞÜS KALP VE DAMAR CERRAHİSİ EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0002-6216-3505
Pages
115–120
Publication Date
2021-08-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, it is aimed to discuss why it is important to make lifestyle changes and some effective methods that can be used in making these changes for patients diagnosed with peripheral artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Peripheral arterial disease is one of the most common cardiovascular diseases that can lead to a decrease in quality of life.
📊
Key Findings & Data:In peripheral vascular diseases, the control of risk factors such as smoking, hypertension, diabetes mellitus and lifestyle changes are very important to prevent complications and stop the progression of the disease.
💡
Conclusion & Impact:In this article, it is aimed to discuss why it is important to make lifestyle changes and some effective methods that can be used in making these changes for patients diagnosed with peripheral artery disease.
🔬Design:Derleme
📍Scope:Comprehensive Sample
⚙️Variables:Hemşirelik · periferik arter hastalıkları · risk faktörleri

Abstract

Peripheral arterial disease is one of the most common cardiovascular diseases that can lead to a decrease in quality of life. In peripheral vascular diseases, the control of risk factors such as smoking, hypertension, diabetes mellitus and lifestyle changes are very important to prevent complications and stop the progression of the disease. In addition to symptom control, lifestyle adjustments such as smoking cessation, walking can improve the functional status and quality of life. In this article, it is aimed to discuss why it is important to make lifestyle changes and some effective methods that can be used in making these changes for patients diagnosed with peripheral artery disease.

Özet

Periferik arter hastalığı, yaşam kalitesinde azalmaya yol açabilen kardiyovasküler hastalıklardan biridir. Periferik damar hastalıklarında, hastalığın ilerlemesini durdurmak ve komplikasyonların önlenmesini sağlamak için risk faktörlerinin (sigara, hipertansiyon, diabetes mellitus gibi) kontrolü ve yaşam tarzı değişikliğinin uygulanması oldukça önemlidir. Semptom kontrolüne ek olarak yaşam tarzında yapılacak olan düzenlemeler (sigaranın bırakılması, yürüyüş gibi) ile fonksiyonel durum ve yaşam kalitesinde iyileşme sağlanabilmektedir. Bu makalede, periferik arter hastalığı tanısı alan hastaların yaşam tarzı değişikliği yapmalarının neden önemli olduğu ve bu değişiklikleri yaparken kullanılabilecek etkili bazı yöntemlerin tartışılması amaçlanmıştır.

🔖

Cite This Article

Kayhan, S. A., Güner, E. (2021). Management of Lifestyle Change in Peripheral Arterial Disease: What Can Be Done?. Sağlık Bilimleri Üniversitesi Hemşirelik Dergisi, Cilt: 3 Sayı: 2, 115–120. https://doi.org/10.48071/sbuhemsirelik.823885

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (39)

  1. Alsadiqi, A.I.M., Subki, A.H., Abushanab, R.H., Ocheltree, M.R., Bajahmom, H.A., Alsadiqi, Y.I.M., & Alhejily, W.A. (2019). Peripheral artery disease risk factors in Jeddah, Saudi Arabia: A retrospectives tudy. International Journal of General Medicine,12, 49-54. doi: 10.2147/ijgm.s176451
  2. Armstrong, E.J., Wu, J., Singh, G.D., Dawson, D.L., Pevec, W.C., & Amsterdam, E.A. (2014). Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. Journal of Vascular Surgery, 60(6), 1565-1571. doi: 10.1016/j.jvs.2014.08.064
  3. Au, T.B., Golledge, J., Walker, P.J., Haigh, K., & Nelson, M. (2013). Peripheral arterial disease: Diagnosis and management in general practice. Australian Family Physician, 42(6), 397-400.
  4. Aydoğdu, S., Güler, K., Bayram, F., Altun, B., Derici, Ü., Abacı, A., … Tokgözoğlu, L. (2019). Türk hipertansiyon uzlaşı raporu 2019. Türk Kardiyoloji Derneği Arşivi, 47(6), 535-546. doi: 10.5543/tkda.2019.
  5. Benjamin, E.J., Muntner, P., Alonso, A., Bittencourt, M.S., Callaway, C.W., Carson, A.P., … Virani, S.S. (2019). Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation, 139(10), 56-528. doi: 10.1161/CIR.0000000000000659
  6. Bonaca, M.P., & Creager, M.A. (2015). Pharmacological treatment and current management of peripheral artery disease. Circulation Research, 116(9), 1579-1598. doi: 10.1161/CIRCRESAHA.114.3035
  7. Burns, P., Gough, S., & Bradbury, A.W. (2003). Management of peripheral arterial disease in primary care. British Medical Journal, 326(7389), 584-588. doi: 10.1136/bmj.326.7389.584
  8. Chi, Y.W., & Jaff, M.R. (2008). Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheterization and Cardiovascular Interventions, 71(4), 475-489. doi: 10.1002/ccd.21401
  9. Criqui, M.H., & Aboyans, V. (2015). Epidemiology of peripheral artery disease. Circulation Research, 116(9), 1509-1526. doi: 10.1161/CIRCRESAHA.116.303849
  10. Demir Korkmaz, F., ve Kankaya, E.A. (2017). Arteriyel yaralar ve hemşirelik bakımı. Türkiye Klinikleri Journal of Surgical Nursing-Special Topics, 3(3), 204-210
  11. Ergul, A. (2011). Endothelin-1 and diabetic complications: Focus on the vasculature. Pharmacological Research, 63(6), 477-482. doi: 10.1016/j.phrs.2011.01.012
  12. Gardner, A.W., & Afaq, A. (2008). Management of lower extremity peripheral arterial disease. Journal of Cardiopulmonary Rehabilitation and Prevention, 28(6), 349-357. doi: 10.1097/HCR.0b013e31818c3b96
  13. Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., Barshes, N.R., Corriere, M.A., Drachman, D.E., … Walsh, M.E. (2017). 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary. Journal of the American College of Cardiology, 69(11), 1465-1508. doi: 10.1016/j.jacc.2016.11.008
  14. Hennrikus, D., Joseph, A.M., Lando, H.A., Duval, S., Ukestad, L., Kodl, M., & Hirsch, A.T. (2010). Effectiveness of a smoking cessation program for peripheral artery disease patients: A randomized controlled trial. Journal of the American College of Cardiology, 56(25), 2105- 2112. doi: 10.1016/j.jacc.2010.07.031
  15. Hirsch, A.T., Murphy, T.P., Lovell, M.B., Twillman, G., Treat-Jacobson, D., Harwood, E.M., … Criqui, M.H. (2007). Gaps in public knowledge of peripheral arterial disease: The first national PAD public awareness survey. Circulation, 116(18), 2086-2094. doi: 10.1161/CIRCULATIONAHA.107.725101
  16. Hobbs, S.D., & Bradbury, A.W. (2003). Smoking cessation strategies in patients with peripheral arterial disease: An evidence-based approach. European Journal of Vascular and Endovascular Surgery, 26(4), 341-347. doi: 10.1016/S1078-5884(03)00356-3
  17. Kalbaugh, C.A., Loehr, L., Wruck, L., Lund, J.L., Matsushita, K., Bengtson, L.G.S., … Kucharska-Newton, A. (2018). Frequency of care and mortality following an incident diagnosis of peripheral artery disease in the inpatient or outpatient setting: The ARIC (Atherosclerosis Risk in Communities) study. Journal of the American Heart Association, 7(8). doi: 10.1161/jaha.117.007332
  18. Karabay, Ö., Karaçelik, M., Yılık, L., Tekin, N., İriz, A.B., Kumdereli, S., … Çalkavur, T. (2012). İskemik periferik arter hastalığı: Bir tarama çalışması. Türk Göğüs Kalp Damar Cerrahisi Dergisi, 20(3), 450-457. doi: 10.5606/tgkdc.dergisi.2012.089
  19. Karadakovan, A., ve Eti Aslan, F. (2010). Dahili ve cerrahi hastalıklarda bakım (4. bs). Ankara: Akademisyen Kitapevi.
  20. Kasper, D., Fauci, A., Hauser, S., Longo, D., Jameson, J.L., & Loscalzo, J. (2008). Harrison’s Principles of Internal Medicine, 19e. Retrieved from (27.03.2021): https://accessmedicine.mhmedical.com/content.aspx?bookid=1130&sectionid=79744227
  21. Khan, S., Cleanthis, M., Smout, J., Flather, M., & Stansby, G. (2005). Life-style modification in peripheral arterial disease. European Journal of Vascular and Endovascular Surgery, 29(1), 2-9. doi: 10.1016/j. ejvs.2004.09.020
  22. Kurultak, İ., ve Calayoğlu, R. (2016). Yoğun bakım hastalarında hipertansiyon. Çağdaş Tıp Dergisi, 6(2), 126-1
  23. Lovell, M., Harris, K., Forbes, T., Twillman, G., Abramson, B., Criqui, M.H., … Hirsch, A.T. (2009). Peripheral arterial disease: Lack of awareness in Canada. Canadian Journal of Cardiology, 25(1), 39-45. doi: 10.1016/S0828-282X(09)70021-2
  24. Lu, L., Mackay, D.F., & Pell, J.P. (2013). Association between level of exposure to second hand smoke and peripheral arterial disease: Cross-sectional study of 5686 never smokers. Atherosclerosis, 229(2), 273-276. doi: 10.1016/j.atherosclerosis.2013.05.015
  25. Mather, K.J. (2013). The vascular endothelium in diabetes-a therapeutic target? Reviews Endocrine and Metabolic Disorders, 14(1), 87-99. doi: 10.1007/s11154-013-9237-9
  26. McDermott, M.M., Guralnik, J.M., Criqui, M.H., Ferruci, L., Liu, K., Spring, B., … Rejeski W.J. (2015). Unsupervised exercise and mobility loss in periphera lartery disease: A randomized controlled trial. Journal of the American Heart Association, 4(5). doi: 10.1161/JAHA.114.001659
  27. McDermott, M.M., Guralnik, J.M., Criqui, M.H., Ferruci, L., Zhao, L., Liu, K., … Rejeski W.J. (2014). Home-based exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. Journal of the American Heart Association, 3(3). doi: 10.1161/JAHA.113.000711
  28. McDermott, M.M., Liu, K., Guralnik, J.M., Cirqui, M.H., Spring, B., Tian, L., … Rejeski, J. (2013). Home-based walking exercise intervention in peripheral artery disease: A randomized clinical trial. The Journal of the American Medical Associtation, 310(1), 57–65. doi: 10.1001/ jama.2013.7231
  29. Murphy, T.P., Cutlip, D.E., & Regensteiner, J.G. (2012). Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: Six-month outcomes from the claudication: Exercise versus endoluminal revascularization (CLEVER) study. Journal of Vascular Surgery, 55(3), 886–887. doi: 10.1016/j. jvs.2012.01.024
  30. Murphy, T.P., Cutlip, D.E., Regensteiner, J.G., Mohler, E.R., Cohen, D.J., Reynolds, M.R., … Hirsch, A.T. (2015). Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: The CLEVER study. Journal of the American College of Cardiology, 65(10), 999–1009. doi: 10.1016/j. jacc.2014.12.043
  31. Olin, J.W., White, C.J., Armstrong, E.J., Kadian-Dodov, D., & Hiatt, W.R. (2016). Peripheral artery disease: Evolving role of exercise, medical therapy, and endovascular options. Journal of the American College of Cardiology, 67(11), 1338-1357. doi: 10.1016/j.jacc.2015.12.049
  32. Paquissi, F.C., Cuvinje, A.B.P., & Cuvinje, A.B. (2016). Prevalence of peripheral arterial disease among adult patient sattending outpatient clinic at a general hospital in South Angola. Scientifica, (2016), 1-6. doi: 10.1155/2016/2520973
  33. Rooke, T.W., Hirsch, A.T., Misra, S., Sidawy, A.N., Beckman, J.A., Findeiss, L.K., … Zierler, R.E. (2011). 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation, 124(18), 2020-2045. doi: 10.1161/ CIR.0b013e31822e80c3
  34. Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M.,. GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology, 76(25), 2982- 3021. doi: 10.1016/j.jacc.2020.11.010
  35. Sadıkoğlu, G., Özçakır, A., Uncu, Y., ve Yıldız, C. (2002). Periferik arter hastalıklarında risk faktörleri ve klinik bulgular. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 28(3), 77-80.
  36. Steffen, L.M., Duprez, D.A., Boucher, L., Ershow, A.G., & Hirsch, A.T. (2008). Management of peripheral arterial disease. Diabetes Spectrum, 21(3), 171-177. doi: 10.2337/diaspect.21.3.171
  37. T.C. Sağlık Bakanlığı. (2017). Obezite ve diyabet klinik rehberi 2017 (Yayın No. 1070). Erişim adresi (07.06.2020): https://hsgm.saglik.gov.tr/ depo/birimler/saglikli-beslenme-hareketli-hayat-db/Diyabet/diyabet-rehberleri/Obezite-ve-Diyabet-Klinik-Rehberi.pdf
  38. Türk Kalp Damar Cerrahisi Derneği, Ulusal Vasküler ve Endovasküler Cerrahi Derneği ve Fleboloji Derneği. (2016). Periferik arter ve ven hastalıkları. Ulusal tedavi kılavuzu 2016. Erişim adresi (27.03.3021): https:// docplayer.biz.tr/47161974-Periferik-arter-ve-ven-hastaliklari.html
  39. Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M.,. GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology, 76(25), 2982- 3021. doi: 10.1016/j.jacc.2020.11.010